Clinical Trial Update: CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on a phase 1/2 clinical trial evaluating CD34+ stem cell selection for patients receiving allogeneic stem cell transplantation …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Bone Marrow Failure
• Diamond-blackfan Anemia
• Hemophagocytic Lymphohistiocytosis
• Langerhans Cell Histiocytosis
• Schwachman-diamond Syndrome
• Sickle Cell Disease
• Sickle Cell-beta-thalassemia

Snippet

Sponsor: Diane George | Conditions: Bone Marrow Failure Syndrome, Severe Aplastic Anemia | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING